"The UC Davis MIND Institute (Medical Investigation of Neurodevelopmental Disorders) is a collaborative international research center, committed to the awareness, understanding, prevention, care, and cures of neurodevelopmental disorders."

During the past decade, UC Davis MIND Institute conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 13 clinical trials were completed, i.e. on average, 39.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 10 clinical trials were completed. i.e. 76.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UC Davis MIND Institute" #1 sponsor was "University of California, Davis" with 21 trials, followed by "Seaside Therapeutics, Inc." with 7 trials sponsored, "Curemark" with 4 trials sponsored, "ACADIA Pharmaceuticals Inc." with 3 trials sponsored and "Zynerba Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UC Davis MIND Institute" #1 collaborator was "National Institute of Mental Health (NIMH)" with 4 trials as a collaborator, "University of California, Davis" with 4 trials as a collaborator, "University of Washington" with 4 trials as a collaborator, "Drexel University" with 2 trials as a collaborator and "University of California, Los Angeles" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "UC Davis MIND Institute" are "Fragile X Syndrome" (17 trials), "Autism" (10 trials), "Autism Spectrum Disorder" (9 trials), "ADHD" (4 trials) and "Attention Deficit Hyperactivity Disorder" (3 trials). Many other conditions were trialed in "UC Davis MIND Institute" in a lesser frequency.

Most popular intervention types in "UC Davis MIND Institute" are "Drug" (34 trials), "Behavioral" (11 trials), "Other" (6 trials), "Device" (5 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "CM-AT" (4 trials), "Arbaclofen" (2 trials), "STX209" (2 trials) and "Sertraline" (2 trials). Other intervention names were less common.

The vast majority of trials in "UC Davis MIND Institute" are 49 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "UC Davis MIND Institute". undefined are not yet recruiting, 12 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 35 completed trials in UC Davis MIND Institute, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UC Davis MIND Institute, 3 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 20 trials that are defined as “Not Applicable".